| 摘要 |
The use in the manufacture of a medicament for the treatment of a chemokine mediated disease state selected from malaria, restinosis, angiogenesis, atherosclerosis, osteoporosis, gingivitis, undesired hematopoietic stem cells release and diseases caused by respiratory viruses, herpes viruses and hepatitis viruses, wherein the chemokine binds to an IL-8 á or â receptor in a mammal of a compound of formulas (I), wherein W, X, R13, R14, v and R20 are as described in the specification.
|
